BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1972726)

  • 1. Behavioral and pharmacologic management of patients with Alzheimer's disease.
    Kahn N; Stoudemire A
    J Med Assoc Ga; 1990 May; 79(5):287-94. PubMed ID: 1972726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease management.
    Rabins PV
    J Clin Psychiatry; 1998; 59 Suppl 13():36-8. PubMed ID: 9771829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Care environments for patients with Alzheimer's disease.
    Abraham IL; Onega LL; Chalifoux ZL; Maes MJ
    Nurs Clin North Am; 1994 Mar; 29(1):157-72. PubMed ID: 8121818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care of the patient with Alzheimer's disease living at home.
    Hall GR
    Nurs Clin North Am; 1988 Mar; 23(1):31-46. PubMed ID: 3347582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing treatment guidelines for Alzheimer's disease and other dementias.
    Rabins PV
    J Clin Psychiatry; 1996; 57 Suppl 14():37-8. PubMed ID: 9024335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and management of behavioral disturbances in Alzheimer's disease.
    Teri L; Logsdon R
    Compr Ther; 1990 May; 16(5):36-42. PubMed ID: 2190750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Alzheimer's disease. A review for the family physician.
    Roth ME
    J Fam Pract; 1993 Dec; 37(6):593-607. PubMed ID: 8245812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    Petrie WM
    Compr Ther; 1985 Jul; 11(7):38-43. PubMed ID: 2863031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of Alzheimer's disease.
    Coll PP; Fortinsky RH; Kaplan R; Song C
    Conn Med; 2003 Sep; 67(8):505-10. PubMed ID: 14587132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and long-term care: the assessment of the patient.
    Reifler BV; Larson EB
    J Geriatr Psychiatry; 1985; 18(1):9-35. PubMed ID: 3935712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of Alzheimer's disease.
    Kumar V; Durai NB; Jobe T
    Clin Geriatr Med; 1998 Feb; 14(1):129-46. PubMed ID: 9456339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease care management plan: maximizing patient care.
    Treinkman A
    J Am Acad Nurse Pract; 2005 Mar; Suppl():8-9. PubMed ID: 16033024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managed care decisions in Alzheimer's disease.
    Fillit HM
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1149-55; discussion S1156-60. PubMed ID: 11142179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease.
    Overshott R; Byrne J; Burns A
    Expert Rev Neurother; 2004 Sep; 4(5):809-21. PubMed ID: 15853508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
    Riva E; Nobili A; Trecate F
    Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
    Gonzalez-Moneo MJ; Simó M; Pie M; Rivero D
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1095-7. PubMed ID: 18613282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.